Does Creatine Raise Creatinine—or Damage Your Kidneys?

Lifters keep getting the same scare: start creatine, creatinine climbs on the next CMP, eGFR looks worse, and someone online declares kidney failure.

What actually changed: A 2025 systematic review and meta-analysis in BMC Nephrology pooled modern creatine trials and found a modest rise in serum creatinine with no significant decline in glomerular filtration rate (GFR) versus control. That is the update worth reading carefully — not a new meme that creatine is “toxic,” and not a free pass to ignore real kidney signals.

This is Research / Evidence Update education for athletes and performance-minded men. It is not a diagnosis, not a creatine dosing protocol, and not medical clearance for any supplement or medication.

Previous Understanding

For years, the athlete story was split in half:

• Gym culture: Creatine is safe; a high creatinine line is “just the creatine.”
• Clinic culture: Creatinine and creatinine-based eGFR are default kidney screens — so a rising number triggers concern.

Both halves contain a grain of truth. Creatinine is a breakdown product of creatine/creatine phosphate metabolism in muscle. More muscle mass, more dietary creatine load, and creatine monohydrate supplementation can increase creatinine generation. Creatinine-based eGFR equations assume production is relatively stable. When production rises for non-filtration reasons, the math can look like filtration fell.

Older case reports and animal work fed the fear. Newer athlete-facing education — including our Advanced Kidney Panel guide — already notes that creatinine can mislead muscular, creatine-using lifters. What was thinner: a crisp evidence update that separates lab artifact / metabolic turnover from true GFR change, and says what still remains unanswered.

New Evidence

Creatinine can rise; GFR does not clearly fall

The 2025 BMC Nephrology meta-analysis reviewed trials and observational designs from 2000–2025. Across pooled creatinine outcomes, creatine supplementation was associated with a small but statistically detectable increase in serum creatinine versus control. Pooled GFR outcomes did not show a statistically significant adverse change.

The authors’ practical reading matches how sports clinicians already talk about this: a creatinine bump after creatine is often a predictable metabolic signal, not automatic proof of nephron injury. Stable filtration measures matter more than a single creatinine “H” flag.

Duration subgroups in that analysis were messy (short-term and longer-term windows showed clearer creatinine effects than a mid-range window). Heterogeneity was high. Assay methods were poorly reported across trials. Treat the direction of the finding as useful; do not turn subgroup noise into a personal protocol calendar.

Cystatin C exists because creatinine is not the whole story

Creatinine-based eGFR alone is a weak sole referee for muscular athletes. Cystatin C is filtered by the glomerulus and is far less tied to muscle mass and creatine intake. Clinical teaching — including Cleveland Clinic Journal of Medicine discussion of cystatin C and eGFR and the broader push toward confirmatory dual-marker strategies when creatinine is hard to interpret — is that cystatin C (and combined creatinine–cystatin C equations when available) can reduce false alarms when body composition or supplements muddy creatinine.

Case-based writing in the nephrology literature makes the same point: creatine or high protein intake can lower creatinine-based eGFR without a matching change in cystatin C–based estimates (“My Kidney Is Fine, Can’t You Cystatin C?”).

For athletes, the useful update is not “ignore creatinine forever.” It is: when creatinine and training/supplement context disagree, add filtration context that is less muscle-dependent — then read urine markers and clinical history with a licensed provider.

Muscle mass still confounds the panel even without a scoop

Creatine is only one confounder. Large lean mass raises baseline creatinine. Acute hard training, dehydration, recent meat-heavy meals, and some medications can move the number too. That is why a single CMP screenshot after a bulk + creatine reload is a terrible diagnosis.

What the Evidence Does NOT Establish

Be precise about the limits:

• It does not prove creatine is risk-free in every clinical kidney disease state, every dose pattern, or every drug combination
• It does not mean every elevated creatinine on creatine is harmless
• It does not replace urine albumin/protein ratios, blood pressure trends, or symptom review
• It does not authorize unsupervised enhancement, NSAID stacking, or “my labs are fine so anything goes”
• It does not turn cystatin C into a DIY green light — markers still need clinical interpretation

Absence of a significant pooled GFR drop in healthy/clinical trial contexts is reassuring for the common athlete question. It is not a universal safety certificate.

Athlete Relevance

This question shows up for a reason:

• Almost every serious lifter has used or considered creatine
• Annual physicals often stop at creatinine/eGFR and never order cystatin C or urine ratios — see why annual physicals skip labs athletes want
• Forum culture collapses “creatinine up” into “kidneys dying”
• Provider notes written for the general population can misread a muscular, creatine-supplemented baseline

Athletes also need the opposite caution: creatine lore can become a shield. True kidney stress still exists. Blood pressure, dehydration, NSAIDs, metabolic disease, and some medication contexts matter more than whether your scoop brand is “micronized.”

If filtration is the open question — not a full hormone rebuild — the Advanced Kidney Panel is built around Cystatin C/eGFR, uric acid/phosphorus context, and urine albumin/protein ratios. For a broader organ/metabolic safety pass that still includes Cystatin C, compare the Anabolic Safety Scan.

Practical Implications

Use the evidence to ask better questions — not to self-clear or self-diagnose.

When creatinine rises after starting creatine:

1. Tell your provider you started creatine (dose pattern, timing relative to the draw)
2. Ask whether hydration, recent training, and meat intake could have inflated the draw
3. Ask whether cystatin C and/or a combined eGFR equation would clarify filtration
4. Ask whether urine albumin-to-creatinine (UACR) or protein-to-creatinine (UPCR) ratios belong in the same conversation
5. Retest on a representative day if advised — one panicked draw after a depleted cut is weak evidence

What “representative” usually means in practice: hydrated, not mid-cut peak dehydration, honest fast if required, and creatine use disclosed. Exact timing instructions come from your clinician and the lab — not from a blog schedule.

Ordering labs without waiting for next year’s physical: Anabolic Insights supports direct panel ordering through licensed workflows. Soft product path: Advanced Kidney Panel when kidney filtration/urine markers are the main event; process overview in how to order blood work without a doctor. Retest cadence context: athlete lab retest cadence.

No proprietary Anabolic Insights aggregate data is available for this article. Do not invent “our users’ average creatinine rise on creatine” claims.

Questions Still Unanswered

Honest gaps remain:

• How cleanly creatinine assays across commercial labs separate creatine interference from true creatinine
• How large the creatinine shift is for very muscular athletes versus mixed trial populations
• How often cystatin C and urine ratios change clinical decisions in everyday sports medicine practice
• Long-term kidney outcomes in people with pre-existing CKD who continue high-dose creatine — evidence is thinner; decisions belong with nephrology-aware clinicians
• How training load, NSAIDs, blood-pressure meds, and GLP-1–related rapid weight loss interact with the creatine–creatinine story in the same person

Those unknowns are why trends + multi-marker context beat a single viral lab screenshot.

Bottom Line

Recent pooled evidence supports a simple athlete translation: creatine can raise serum creatinine without a matching signal that GFR has fallen. Creatinine-only panic is often the wrong move. Creatinine-only complacency is also the wrong move.

Better frame: disclose creatine use, interpret creatinine with muscle and supplement context, add cystatin C and urine markers when the filtration question is real, and let a licensed provider decide what needs retesting or further workup.

FAQs

Does creatine damage kidneys in healthy athletes?

Pooled trial evidence does not show a clear adverse GFR effect from standard creatine use in the populations studied. That is not the same as “safe for every medical history.” Pre-existing kidney disease and complex medication lists need individualized clinician review.

Why did my eGFR drop after I started creatine?

Creatinine-based eGFR can look worse when creatinine production rises, even if filtration is unchanged. Ask about cystatin C or a combined equation before treating the number as a diagnosis.

Should I stop creatine before blood work?

Some clinicians prefer a pause before kidney labs; others interpret results with ongoing use disclosed. Do not invent a washout schedule from a forum. Ask the ordering provider what they want for your draw.

Is cystatin C always better than creatinine?

It is often more useful when muscle mass or creatine muddies creatinine. It is not magic, not a full kidney workup by itself, and still needs clinical context.

When is a dedicated kidney panel worth considering?

When creatinine keeps looking “high,” when you need urine albumin/protein ratios, or when filtration — not hormones — is the primary open question. That is the job of the Advanced Kidney Panel, interpreted with a licensed provider.